Quantcast
Home > Quotes > ANIK
ANIK

Anika Therapeutics Inc. Common Stock (ANIK) Quote & Summary Data

$35.71
*  
0.80
2.29%
Get ANIK Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading ANIK now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
41.5
Today's High / Low
$ 36.05 / $ 34.3911
Share Volume
78,101
50 Day Avg. Daily Volume
93,709
Previous Close
$ 34.91
52 Week High / Low
$ 69.8069 / $ 28.54
Market Cap
507,491,129
P/E Ratio
27.9
Forward P/E (1y)
Earnings Per Share (EPS)
$ 1.28
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.73

Intraday Chart

Shares Traded

Share Volume:
78,101
50 Day Avg. Daily Volume:
93,709

P/E Ratio

P/E Ratio:
27.9
Forward P/E (1y):
Earnings Per Share (EPS):
$ 1.28

Trading Range

The current last sale of $35.71 is 25.12% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 36.05 $ 69.8069
 Low: $ 34.3911 $ 28.54

Company Description (as filed with the SEC)

We are a global, integrated orthopedic medicines company committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative tissue repair. We have over two decades of global expertise developing, manufacturing, and commercializing products based on our proprietary hyaluronic acid ("HA") technology. Our orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. Our therapeutic offerings consist of products in the following areas: Orthobiologics, Dermal, Surgical, and Other, which includes our ophthalmic and veterinary products. All of our products are based on HA, a naturally occurring, biocompatible polymer found throughout the body.  ... More ...  


Risk Grade

Where does ANIK fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 34.48
Open Date:
Nov. 16, 2018
Close Price:
$ 34.91
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x